DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Osmotica Pharmaceuticals Q4 EPS $(0.51) Does Not Compare To $(0.09) Estimate, Sales $59.9M Beat $53.23M Estimate

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.09) by 466.67 percent. This is a 27.5 percent decrease over losses of $(0.4) per

Benzinga · 03/18/2020 20:10

Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.09) by 466.67 percent. This is a 27.5 percent decrease over losses of $(0.4) per share from the same period last year. The company reported quarterly sales of $59.9 million which beat the analyst consensus estimate of $53.23 million by 12.53 percent. This is a 8.82 percent decrease over sales of $65.697 million the same period last year.